Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0YZ
|
|||
Former ID |
DIB018048
|
|||
Drug Name |
UK-356202
|
|||
Synonyms |
compound 13j [PMID: 15149680]; UK-356,202
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Myocardial hypertrophy [ICD-11: BC45; ICD-10: I51.7] | Clinical trial | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C17H13ClN4O2
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)C(=O)O)C2=CC3=C(C=C2)C(=CN=C3N=C(N)N)Cl
|
|||
InChI |
1S/C17H13ClN4O2/c18-14-8-21-15(22-17(19)20)13-7-10(4-5-12(13)14)9-2-1-3-11(6-9)16(23)24/h1-8H,(H,23,24)(H4,19,20,21,22)
|
|||
InChIKey |
UXNWIRHZMHGOCE-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 223671-94-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidines. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3227-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.